Roivant Sciences(ROIV) - 2026 Q3 - Earnings Call Transcript

Roivant Sciences (NasdaqGS:ROIV) Q3 2026 Earnings call February 06, 2026 08:00 AM ET Company ParticipantsBenjamin Zimmer - CEOMatt Gline - CEOStephanie Lee - Head of Investor RelationsNone - Company RepresentativeConference Call ParticipantsAlexander Thompson - Managing Director, and Senior Equity Research AnalystAshwani Verma - Executive Director of SMID Biotech and Biopharma, and Equity Research AnalystBrian Cheng - Executive Director, and Senior Biotech AnalystCorinne Johnson - Managing Director of Equit ...